Who owns RVMD?
Institutional ownership of Revolution Medicines Inc. from Form 13F, Q2 2026
690 institutional managers reported holding Revolution Medicines Inc. (RVMD) in Form 13F filings for Q2 2026, with 214,092,384 shares worth $40.2B. The largest reported holder was BlackRock, Inc. Managers that filed both quarters added a net 14,483,596 shares (+7.7%). 232 opened new positions and 61 sold out.
- Funds holding
- 690
- Value held
- $40.2B
- New / sold out
- 232 / 61
- Net shares, same filers
- +7.7%
Holdings as of June 30, 2026, the end of Q2 2026. Managers have 45 days after a quarter ends to file Form 13F (by August 14, 2026 for Q2 2026), so positions may have changed since.
Largest holders of RVMD
| Fund | Value | Share of 13F holdings | Shares | Move |
|---|---|---|---|---|
| BlackRock, Inc. | $2.6B | 6.4% | 13,695,790 | Added |
| Farallon Capital Management, L.l.c. | $2.5B | 6.3% | 13,550,796 | Trimmed |
| FMR LLC | $2.3B | 5.7% | 12,200,422 | Added |
| Baker Bros. Advisors LP | $2.1B | 5.3% | 11,443,357 | Added |
| Darwin Global Management, Ltd. | $2.0B | 5.0% | 10,629,822 | Added |
| Jupiter Topco LLC | $2.0B | 5.0% | 10,736,145 | First report |
| Vanguard Capital Management LLC | $1.7B | 4.2% | 9,088,661 | Added |
| Vanguard Portfolio Management LLC | $1.6B | 3.9% | 8,294,855 | Added |
| Nextech Invest Ltd. | $1.4B | 3.6% | 7,601,087 | Unchanged |
| Paradigm Biocapital Advisors LP | $1.2B | 3.0% | 6,361,323 | Trimmed |
| UBS Group AG | $1.0B | 2.5% | 5,448,364 | Added |
| State Street Corp | $917M | 2.3% | 4,897,051 | Added |
| Capital World Investors | $751M | 1.9% | 4,008,244 | New |
| Geode Capital Management, LLC | $737M | 1.8% | 3,942,676 | Added |
| Wellington Management Group LLP | $720M | 1.8% | 3,843,415 | Trimmed |
| JPMorgan Chase & Co | $637M | 1.5% | 3,298,066 | Added |
| BVF Inc | $555M | 1.4% | 2,965,160 | Added |
| Alphabet Inc. | $552M | 1.4% | 2,946,619 | Trimmed |
| Casdin Capital, LLC | $483M | 1.2% | 2,577,333 | Unchanged |
| Deerfield Management Company, L.p. | $448M | 1.1% | 2,392,000 | Added |
| Price T Rowe Associates Inc | $448M | 1.1% | 2,390,303 | Trimmed |
| Avoro Capital Advisors LLC | $430M | 1.1% | 2,297,000 | Trimmed |
| Norges Bank | $404M | 1.0% | 2,157,479 | New |
| Goldman Sachs Group Inc | $399M | 1.0% | 2,133,101 | Trimmed |
| Nearwater Capital Markets, Ltd | $393M | 1.0% | 2,097,000 | Added |
Share of 13F holdings is each fund's shares as a share of the 214,092,384 RVMD shares all 13F filers reported, not of shares outstanding.
Biggest buyers in Q2 2026
- Darwin Global Management, Ltd. Added+$1.6B
- Capital World Investors New+$751M
- FMR LLC Added+$700M
- JPMorgan Chase & Co Added+$579M
- BlackRock, Inc. Added+$465M
- Norges Bank New+$404M
- Massachusetts Financial Services Co New+$377M
- Baker Bros. Advisors LP Added+$354M
- Nearwater Capital Markets, Ltd Added+$266M
- AQR Capital Management LLC Added+$221M
Biggest sellers in Q2 2026
- Adage Capital Partners GP, L.l.c. Trimmed-$914M
- Wellington Management Group LLP Trimmed-$409M
- Vestal Point Capital, LP Trimmed-$361M
- Abu Dhabi Investment Council Co P.J.S.C Trimmed-$300M
- Logos Global Management LP Trimmed-$243M
- Alyeska Investment Group, L.P. Trimmed-$230M
- Holocene Advisors, LP Trimmed-$208M
- D. E. Shaw & Co., Inc. Trimmed-$189M
- Westfield Capital Management Co LP Trimmed-$179M
- Price T Rowe Associates Inc Trimmed-$158M
The change in shares since the quarter before, adjusted for stock splits and priced at the Q2 2026 value per share. Funds bought $8.8B and sold $5.7B; 239 added and 148 trimmed.
Schedule 13D and 13G filings on RVMD
Owners of more than 5% must file within days, so these can be newer than the 13F data.
- 2026-08-13Janus Henderson Group Ltd. SCHEDULE 13G filed by Revolution Medicines Inc.Schedule 13G
- 2026-07-29BlackRock, Inc. SCHEDULE 13G filed by BlackRock Inc.Schedule 13G
- 2025-11-05FMR LLC SCHEDULE 13G filed by Revolution Medicines Inc.Schedule 13G
- 2025-08-14BAKER BROS. ADVISORS LP SCHEDULE 13G filed by Revolution Medicines Inc.Schedule 13G
- 2025-05-15Farallon Capital Partners, L.P. SCHEDULE 13G filed by Revolution Medicines Inc.Schedule 13G
- 2025-02-14JANUS HENDERSON GROUP PLC SCHEDULE 13G filed by Revolution Medicines Inc.Schedule 13G
Questions about RVMD ownership
- Who owns RVMD stock?
- 690 institutional investment managers reported RVMD positions in their Form 13F filings for Q2 2026, holding 214,092,384 shares worth $40.2B in total. BlackRock, Inc. reported the largest position.
- Are funds buying or selling RVMD?
- In Q2 2026, 232 managers opened new RVMD positions, 239 added, 148 trimmed and 61 sold out. Managers that filed in both quarters added a net 14,483,596 shares.
- How current is this RVMD institutional ownership data?
- It covers holdings as of the end of Q2 2026. Managers have 45 days after the quarter ends to file Form 13F (by August 14, 2026 for Q2 2026), so positions may have changed since.
From the SEC's Form 13F data sets for Q2 2026: every 13F holdings report, matched to RVMD by CUSIP. Options are left out. RVMD news and filings · RVMD insider trades · Top funds